| NCT07334977 | Synergistic Effect of Non-invasive Brain and Spinal Cord Stimulation | Centre National de la Recherche Scientifique, France | | - Age ≥ 18 yrs
- Level C1-T1
AIS A, B, C, D- All
- NOT have implanted medical devices (cardiac valve, endovascular devices, ventricular shunt valve, surgical clips, metallic sutures, staples, stent, osteosynthesis or arthrodesis hardware)
| Recruiting | 45 | PHASE2 | Technology | Arm/hand function | - Feasibility
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Surface Electromyography (sEMG)
| 25 days | 11 December 2024 | 12 January 2026 | 2 | |
| NCT07369349 | Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients | Saglik Bilimleri Universitesi | | - Age 18 - 65 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 34 | NA | Psychosocial/other | Bowel health | - Neurogenic Bowel Dysfunction Score (NBD or NBDS)
| 12 weeks | 20 February 2026 | 27 January 2026 | 0 | |
| NCT07303582 | Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities | Oxford University Hospitals NHS Trust | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
| Recruiting | 50 | PHASE4 | Drug | Pain | - Ashworth and Modified Ashworth Scale (MAS)
- Barthel Index (BI)
- European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
- Goal Attainment Scaling (GAS) score
- Neuropathoc Pain Symptom Inventory (NPSI)
- Surface Electromyography (sEMG)
| 24 weeks | 02 December 2025 | 26 December 2025 | 1 | |
| NCT07251491 | Psilocybin to Treat Depression in Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age ≥ 22 yrs
- Level C1-S5
AIS - ≥ 12 months
- have a confirmed diagnosis of depression
| Recruiting soon | 30 | PHASE1, PHASE2 | Drug | Mental health and psychosocial factors | - Adverse Events (AEs)
- Beck Depression Inventory (BDI)
| 13 months | 01 January 2026 | 26 November 2025 | 1 | |
| NCT06793683 | Early BOTOX After Spinal Cord Injury | University of Washington | | - Age 18 - 65 yrs
- Level C1-T6
AIS A, B- ≤ 20 weeks
| By invitation | 10 | EARLY_PHASE1 | Drug | Bladder health/function | - Adverse Events (AEs)
- Feasibility
| 1 year | 27 July 2024 | 27 January 2025 | 1 | |
| NCT07343583 | Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury | Ankara City Hospital Bilkent | | - Age 18 - 65 yrs
- Level C1-T11
AIS - ≤ 6 months
- NOT have a cardiac pacemaker
| Recruiting | 45 | NA | Technology | Bladder health/function | - Neurogenic Bladder Symptom Score
- Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Spinal Cord Independence Measure (SCIM)
- Urodynamic examination
| 2 months | 05 August 2025 | 15 January 2026 | 1 | |
